Latest News and Press Releases

CLEVELAND, Sept. 25, 2018 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, today announced that Christopher Gilmore, MD of Carolinas Pain...

SPRINT® is the First and Only Dual Lead Capable PNS Platform Company also provides first look at 12-month durability outcomes following 60-day SPRINT therapy CLEVELAND, Aug. 16, 2018 (GLOBE...

CLEVELAND, Sept. 12, 2017 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., (SPR) a private medical device company that has developed a novel neurostimulation technology for chronic and acute pain,...

CLEVELAND, Sept. 07, 2017 (GLOBE NEWSWIRE) -- SPR® Therapeutics, LLC (SPR), a private medical device company that has developed a novel, evidence-based neurostimulation platform for chronic and...

CLEVELAND, Ohio, Aug. 03, 2017 (GLOBE NEWSWIRE) -- Patients in need of a total knee replacement (TKR) often delay surgery by two or more years because of concerns about the duration of postoperative...

CLEVELAND, May 15, 2017 (GLOBE NEWSWIRE) -- SPR Therapeutics (SPR) has been awarded a $6M four-year contract from the U.S. Department of Defense (DoD) to further advance its SPRINT™ Peripheral Nerve...

CLEVELAND, March 21, 2017 (GLOBE NEWSWIRE) -- SPR Therapeutics, LLC, a private medical device company that has developed a novel, evidence-based neurostimulation platform for chronic and acute pain,...

CLEVELAND, Jan. 19, 2017 (GLOBE NEWSWIRE) -- The National Association of Corporate Directors (NACD) has named SPR® Therapeutics’ Board Member, Les C. Vinney, one of the top 100 most influential...

CLEVELAND, Jan. 17, 2017 (GLOBE NEWSWIRE) -- SPR® Therapeutics announced today that industry veteran, Dave Youngberg, has joined the neurostimulation company as Vice President of Sales. ...